Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2024

Open Access 25.07.2023 | Images in Obstetrics and Gynecology

Prenatal diagnosis of a fetal harlequin ichthyosis

verfasst von: Tobias Spingler, Cornelia Wiechers, Markus Hoopmann, Karl Oliver Kagan

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2024

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A 24-year-old woman (gravida 2, para 1) was referred at 30 week gestation due to an abnormal fetal profile on prenatal ultrasound and reduced fetal movements. Our ultrasound examination showed the typical dysmorphic facial features of harlequin ichthyosis (HI) including ectropion of the eyelids, outward turning of the lip (eclabium) with an open mouth, and the typical profile. In addition, the joints were immobile and the position of the fingers and toes was abnormal. Interestingly, respiratory movements were still visible. After counseling, the couple decided to terminate the pregnancy Fig. 1.
The figure includes some typical features of HI on ultrasound: 3D image of the face with an open mouth (upper left), profile (lower right), and ectropion (denoted by arrows) (lower left). The upper right is a corresponding postnatal image.
HI is a severe and rare autosomal recessive ichthyosis with a prevalence of approximately 1 in 300 000 births [1]. The disease is caused by a mutation in the lipid transporter adenosine triphosphate-binding cassette A 12 (ABCA12) [2]. Prenatally, typical signs of the disease, such as ectropion, eclabium, dense suspended particles in the amniotic fluid, rudimentary ears, and contractures, are not detectable until the second trimester, so early detection in pregnancy is not possible. Affected children also show armor-like thickening of the skin, which can lead to pseudocontractures and necrosis.
Therapy for HI includes intensive neonatal care and administration of retinoids such as oral acitretin within the first 7 days of life. Even though this therapeutical approach improves the survival rate, 75% of the neonates still die within the first 3 months of life, usually due to sepsis or respiratory failure [3, 4].

Declarations

Conflict of interest

The authors have not disclosed any competing interests.

Ethical approval

No ethical approval was required.
Written informed consent was obtained from the parents.
The authors affirm that the human research participants provided informed consent for publication of the images. All authors have agreed to publish this manuscript in Archives of Gynecology and Obstetrics.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Gynäkologie

Kombi-Abonnement

Mit e.Med Gynäkologie erhalten Sie Zugang zu CME-Fortbildungen der beiden Fachgebiete, den Premium-Inhalten der Fachzeitschriften, inklusive einer gedruckten gynäkologischen oder urologischen Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat Ahmed H, O’Toole EA (2014) Recent advances in the genetics and management of harlequin ichthyosis. Pediatr Dermatol 31(5):539–546CrossRefPubMed Ahmed H, O’Toole EA (2014) Recent advances in the genetics and management of harlequin ichthyosis. Pediatr Dermatol 31(5):539–546CrossRefPubMed
2.
Zurück zum Zitat Akiyama M et al (2005) Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 115(7):1777–1784CrossRefPubMedPubMedCentral Akiyama M et al (2005) Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Invest 115(7):1777–1784CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Rajpopat S et al (2011) Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol 147(6):681–686CrossRefPubMed Rajpopat S et al (2011) Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol 147(6):681–686CrossRefPubMed
4.
Zurück zum Zitat Shibata A et al (2014) High survival rate of harlequin ichthyosis in Japan. J Am Acad Dermatol 70(2):387–388CrossRefPubMed Shibata A et al (2014) High survival rate of harlequin ichthyosis in Japan. J Am Acad Dermatol 70(2):387–388CrossRefPubMed
Metadaten
Titel
Prenatal diagnosis of a fetal harlequin ichthyosis
verfasst von
Tobias Spingler
Cornelia Wiechers
Markus Hoopmann
Karl Oliver Kagan
Publikationsdatum
25.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2024
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-023-07164-9

Weitere Artikel der Ausgabe 4/2024

Archives of Gynecology and Obstetrics 4/2024 Zur Ausgabe

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Menopausale Hormontherapie für Frauen über 65?

07.05.2024 Klimakterium und Menopause Nachrichten

In den USA erhalten nicht wenige Frauen auch noch im Alter über 65 eine menopausale Hormontherapie. Welche positiven und negativen gesundheitlichen Konsequenzen daraus möglicherweise resultieren, wurde anhand von Versicherungsdaten analysiert.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.